Updated: June 05, 2020 07:51 PM
Created: June 05, 2020 05:03 PM
A new case study involving New York Oncology Hematology, may have found a treatment for the severe breathing problems many coronavirus patients experience.
Ventilators are used when the oxygen level in these patients falls dangerously low.
The oxygen drop happens because of a cytokine storm, which is when the body goes into overdrive to fight the virus but ends up causing inflammation and potentially deadly damage.
A researcher at U.S. Oncology, parent company of NYOH, theorized a cancer drug, acalabrutinib, could tamp down that immune response, and it did.
Copyright 2020 - WNYT-TV, LLC A Hubbard Broadcasting Company